Pacific Biosciences Of California (PACB) Change in Cash (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Change in Cash of -$7.4 million for Q1 2026, down 335.73% year-over-year from $3.1 million in Q1 2025, and down 206.25% quarter-over-quarter from $7.0 million in Q4 2025.
Pacific Biosciences Of California (PACB) Change in Cash (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Change in Cash history runs 17 years deep, the most recent figure standing at -$7.4 million for Q1 2026.
- In Q1 2026, Change in Cash fell 335.73% year-over-year to -$7.4 million; the TTM figure through Mar 2026 stood at -$2.9 million (up 84.63% YoY), while the FY2025 annual figure was $7.7 million, up 106.13% from the prior year.
- Change in Cash for Q1 2026 stood at -$7.4 million, down from $7.0 million in the prior quarter.
- The five-year high for Change in Cash was $176.4 million in Q3 2023, with the low at -$205.7 million in Q4 2023.
- The 5-year median for Change in Cash is -$6.0 million (2022), against an average of -$24.0 million.
- Peak annual rise in Change in Cash reached 3033.48% in 2023, while the deepest fall reached 1096.02% in 2023.
- Pacific Biosciences Of California's Change in Cash stood at $20.7 million in 2022, then tumbled by 1096.02% to -$205.7 million in 2023, then jumped by 89.01% to -$22.6 million in 2024, then surged by 130.78% to $7.0 million in 2025, then plunged by 206.25% to -$7.4 million in 2026.
- Business Quant data shows PACB's Change in Cash at -$7.4 million in Q1 2026, $7.0 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 513.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -890.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 462.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -13.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -180.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.21 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 42.80 Mn |
| 10 | Pacific Biosciences Of California | 419.38 Mn | 182.51 Mn | 12.64 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.74 Mn |
| Mar 31, 2026 | -7.40 Mn |
| Dec 31, 2025 | 6.96 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | -4.09 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | -22.61 Mn |
| Sep 30, 2024 | -21.59 Mn |
| Jun 30, 2024 | 22.42 Mn |
| Mar 31, 2024 | -103.27 Mn |
| Dec 31, 2023 | -205.74 Mn |
| Sep 30, 2023 | 176.36 Mn |
| Jun 30, 2023 | -145.05 Mn |
| Mar 31, 2023 | 28.75 Mn |
| Dec 31, 2022 | 20.66 Mn |
| Sep 30, 2022 | -6.01 Mn |
| Jun 30, 2022 | -120.39 Mn |
| Mar 31, 2022 | -31.76 Mn |
| Dec 31, 2021 | 35.37 Mn |
| Jun 30, 2021 | -473.64 Mn |